Merck, through its global innovation fund, and Windham Venture Partners invested $20 million in WellDoc. The mHealth firm said the money will help it launch and commercialize BlueStar, its FDA-approved, prescription-based mobile therapy for type 2 diabetes.
Consultants TGaS Advisors promoted seven employees and took on one: Sue Lipinski, who had headed the health and wellness arm of digital agency Razorfish, is now director, management advisor.
Johnson & Johnson’s Wellness & Prevention division launched a seven-minute workout app. The tool includes an intense aerobic and resistance-training regimen and 12 other workouts that J&J says can be cut and pasted to create more than 1,000 variations.
AdhereTech has added a tool to patient adherence: a HIPPA-compliant pill bottle that sends text messages or places phone calls to remind patients about their medication. The bottle also compiles anonymous demographic, condition and drug data. TechCrunch reports that the company plans to partner with drug companies “particularly for very expensive drugs.” The device won the 2013 Healthcare Innovation World Cup.
From the February 01, 2014 Issue of MM+M - Medical Marketing and Media
